Origin of α-mannosidase activity in CSF.

[1]  P. Calabresi,et al.  Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies , 2015, Molecular Neurodegeneration.

[2]  P. Calabresi,et al.  Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid , 2014, PloS one.

[3]  C. Teunissen,et al.  Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. , 2014, Journal of proteomics.

[4]  T. Foltynie,et al.  Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells , 2014, Brain : a journal of neurology.

[5]  D. Hartmann,et al.  Accumulation of Free Oligosaccharides and Tissue Damage in Cytosolic α-Mannosidase (Man2c1)-deficient Mice , 2014, The Journal of Biological Chemistry.

[6]  P. Calabresi,et al.  Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Urayama.  Toward the successful delivery of lysosomal enzymes across the blood–brain barrier , 2013 .

[8]  Frances M. Platt,et al.  Lysosomal storage disorders: The cellular impact of lysosomal dysfunction , 2012, The Journal of cell biology.

[9]  Zhenghong Qin,et al.  Parkinson's disease involves autophagy and abnormal distribution of cathepsin L , 2011, Neuroscience Letters.

[10]  P. Calabresi,et al.  Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies , 2009, Neurobiology of Disease.

[11]  R. D'Hooge,et al.  Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice. , 2008, Human molecular genetics.

[12]  D. Begley,et al.  Lysosomal storage diseases and the blood-brain barrier. , 2008, Current pharmaceutical design.

[13]  T. Beccari,et al.  Cloning and expression of mouse cytosolic alpha-mannosidase (Man2c1). , 2006, Biochimica et biophysica acta.

[14]  C. Czupalla,et al.  Proteomic Analysis of Lysosomal Acid Hydrolases Secreted by Osteoclasts , 2006, Molecular & Cellular Proteomics.

[15]  W. Sly,et al.  Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Beccari,et al.  beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[17]  T. Beccari,et al.  β-Hexosaminidase, α-d-mannosidase, and β-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I , 2000 .

[18]  S. Stinchi,et al.  Lysosomal α-D-mannosidase , 1999 .

[19]  S. Stinchi,et al.  Lysosomal alpha-mannosidases of mouse tissues: characteristics of the isoenzymes, and cloning and expression of a full-length cDNA. , 1997, The Biochemical journal.

[20]  R. Nixon,et al.  Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.

[21]  J. Vonsattel,et al.  Elevated Levels of the Endosomal‐Lysosomal Proteinase Cathepsin D in Cerebrospinal Fluid in Alzheimer Disease , 1995, Journal of neurochemistry.

[22]  C. Warren,et al.  Mammalian α-mannosidases—multiple forms but a common purpose? , 1994 .

[23]  J. Wieruszeski,et al.  Soluble forms of alpha-D-mannosidases from rat liver. Separation and characterization of two enzymic forms with different substrate specificities. , 1994, European journal of biochemistry.

[24]  R. Kornfeld,et al.  The soluble form of rat liver alpha-mannosidase is immunologically related to the endoplasmic reticulum membrane alpha-mannosidase. , 1986, The Journal of biological chemistry.

[25]  B. Winchester,et al.  The multiple forms of alpha-D-mannosidase in human plasma. , 1979, The Biochemical journal.

[26]  B. Hultberg,et al.  Neutral α-mannosidase activity in human serum , 1976 .

[27]  O. Touster,et al.  Purification and characterization of the alpha-D-mannosidase of rat liver cytosol. , 1976, The Journal of biological chemistry.

[28]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[29]  N. Phillips,et al.  Characterization of human liver alpha-D-mannosidase purified by affinity chromatography. , 1976, The Biochemical journal.

[30]  C. Vite,et al.  Clinical Improvement of Alpha-mannosidosis Cat Following a Single Cisterna Magna Infusion of AAV1. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  P. Calabresi,et al.  Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[32]  T. Braulke,et al.  Mannose phosphorylation in health and disease. , 2010, European journal of cell biology.

[33]  S. Stinchi,et al.  Lysosomal alpha-D-mannosidase. , 1999, Bioscience reports.

[34]  C. Warren,et al.  Mammalian alpha-mannosidases--multiple forms but a common purpose? , 1994, Glycobiology.

[35]  S. Malcolm,et al.  Purification and comparison of the structures of human liver acidic α-d-mannosidases A and B , 1986 .

[36]  S. Malcolm,et al.  Purification and comparison of the structures of human liver acidic alpha-D-mannosidases A and B. , 1986, The Biochemical journal.

[37]  B. Hultberg,et al.  Neutral alpha-mannosidase activity in human serum. , 1976, Biochimica et biophysica acta.